港股午評:三大指數齊跌 藥明繫個股大幅下跌 京東業績超預期超6%
格隆匯3月7日丨港股三大指數臨近午盤全部由升轉跌,恒生科技指數最終下跌0.87%,恒指、國指分別下跌0.47%及0.09%,未能延續昨日強勢上升行情。

盤面上,大型科技股集體表現低迷,網易跌5%,阿里巴巴、百度、騰訊、快手均跌超1%,惟京東績後大升6%表現強勢;美參議院版《生物安全法案》昨夜聽證會通過,生物科技股大跌居前,藥明繫個股跌幅較大;iPhone在華銷量下降24%,蘋果美股錄得6連跌,蘋果概念股亦全線走低;體育用品股、手遊股、汽車股、餐飲股多數下跌。 另一方面,美聯儲降息預期升温國際金價再創新高,黃金股繼續保持強勢上升行情,紫金礦業5連升逼近上市高價,隔夜國際油價上揚推動三桶油齊升,中國海洋石油再創歷史新高。行情,紫金礦業5連升逼近上市高價,隔晚國際油價上揚推動三桶油齊升,中國海洋石油再創歷史新高。
板塊方面
金價續創新高,黃金股集體走強,紫金礦業5連升創3年新高。美聯儲主席鮑威爾昨晚重申很可能在今年內減息。利率期貨數據顯示,交易商預料美聯儲6月減息可能性是70%。消息牽動美匯跌至一個月低位,利好金價。國際金價週三持續上升,再創紀錄新高。紐約期金收市升0.76%,每盎斯報2158.2美元。現貨金最高升1.14%,每盎司高見2152.22美元,收市報2148.14美元,上揚0.95%。鈀金重返每盎斯1000美元以上,是1月12日以來新高。

國際油價上升,中海油續創新高。昨日國際油價上揚,紐約期油每桶收報79.13美元,升幅近1.3%。倫敦布倫特期油每桶收報82.96美元,升幅為1.1%。

美參議院版《生物安全法案》獲通過,藥明系大跌。消息面上,當地時間3月6日上午,在美國參議院國土安全與政府事務委員會召開的聽證會上,參院版的《生物安全法案》(編號:S.3558)以壓倒性的同意票數獲得通過。該法案由參議員加里·彼得斯(Gary Peters)提出,目的在於禁止美國聯邦政府與某些跟外國競爭對手有聯繫的生物技術提供商簽訂合同,包括華大基因、藥明康德等企業被點名。在此之前,該法案已經經歷過一次聽證推遲。另據瞭解,由眾議員邁克·加拉格爾(Mike Gallagher)發起的《生物安全法案》(BIOSECURE Act,編號:H.R.7085)也將於當地時間3月7日上午9點在眾議院舉行聽證會。

個股方面
京東大升6%,Q4營收超預期,計劃啟動30億美元回購計劃。公司2023年Q4營收3061億元,上年同期2954億元,市場預期2999億元;2023年全年收入為人民幣10,847億元,較2022年全年增加3.7%。 京東董事會已批准一項新股份回購計劃,於公司現有股份回購計劃於2024年3月17日屆滿後生效。根據新股份回購計劃,公司可於截至2027年3月的未來36個月內回購價值不超過30億美元的股份。

第四範式飆升逾71%續創新高,月內股價翻逾一倍。中信證券發佈研報,指第四範式是國內AI平台領跑者,引領前沿技術研發,提供以平台為中心的企業級端到端人工智能解決方案。在客户規模和客户價值雙輪驅動下,營收持續高速增長,預計公司2023-2025年營業收入為40.47/50.94/62.33億元,同比增速分別為31.3%/25.9%/22.4%,規模效應下有望逐步扭虧並提高盈利能力。我國人工智能市場高速發展助力各行各業轉型升級,一方面,以平台為中心的決策類AI是公司核心優勢,公司有望充分受益企業數智化轉型帶來的滲透率提升;另一方面,公司推出大模型產品式説(SageGPT),加速佈局生成式AI領域,以期重構企業級AI應用,打開更廣闊空間。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.